BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30290804)

  • 1. Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.
    Wu-Chou YH; Hung TC; Lin YT; Cheng HW; Lin JL; Lin CH; Yu CC; Chen KT; Yeh TH; Chen YR
    J Biomed Sci; 2018 Oct; 25(1):72. PubMed ID: 30290804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Detection of
    Bianchessi D; Ibba MC; Saletti V; Blasa S; Langella T; Paterra R; Cagnoli GA; Melloni G; Scuvera G; Natacci F; Cesaretti C; Finocchiaro G; Eoli M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF1 single and multi-exons copy number variations in neurofibromatosis type 1.
    Imbard A; Pasmant E; Sabbagh A; Luscan A; Soares M; Goussard P; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanne-Chantelot C; Vidaud D; Wolkenstein P; ; Parfait B
    J Hum Genet; 2015 Apr; 60(4):221-4. PubMed ID: 25631097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type I: mutation spectrum of NF1 in spanish patients.
    Palma Milla C; Lezana Rosales JM; López Montiel J; Andrés Garrido LD; Sánchez Linares C; Carmona Tamajón S; Torres Fernández C; Sánchez González P; Franco Freire S; Benito López C; López Siles J
    Ann Hum Genet; 2018 Nov; 82(6):425-436. PubMed ID: 30014477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation panel sequencing identifies
    Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
    Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
    Yap YS; Munusamy P; Lim C; Chan CHT; Prawira A; Loke SY; Lim SH; Ong KW; Yong WS; Ng SBH; Tan IBH; Callen DF; Lim JCT; Thike AA; Tan PH; Lee ASG
    Breast Cancer Res Treat; 2018 Oct; 171(3):719-735. PubMed ID: 29926297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exonic deletions in the NF1 gene in patients with neurofibromatosis type I from the lower Silesian region of Poland.
    Laczmańska I; Szczepaniak M; Jakubiak A; Stembalska A
    Adv Clin Exp Med; 2014; 23(4):517-21. PubMed ID: 25166435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.
    De Luca A; Bottillo I; Dasdia MC; Morella A; Lanari V; Bernardini L; Divona L; Giustini S; Sinibaldi L; Novelli A; Torrente I; Schirinzi A; Dallapiccola B
    J Med Genet; 2007 Dec; 44(12):800-8. PubMed ID: 18055911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Analyses of the
    Ulusal SD; Gürkan H; Atlı E; Özal SA; Çiftdemir M; Tozkır H; Karal Y; Güçlü H; Eker D; Görker I
    Balkan J Med Genet; 2017 Jun; 20(1):13-20. PubMed ID: 28924536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Molecular and Clinical Findings in Children With Neurofibromatosis Type 1: Identification of 15 Novel Variants.
    Bildirici Y; Kocaaga A; Karademir-Arslan CN; Yimenicioglu S
    Pediatr Neurol; 2023 Dec; 149():69-74. PubMed ID: 37806041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA.
    Tsipi M; Poulou M; Fylaktou I; Kosma K; Tsoutsou E; Pons MR; Kokkinou E; Kitsiou-Tzeli S; Fryssira H; Tzetis M
    J Neurol Sci; 2018 Dec; 395():95-105. PubMed ID: 30308447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Mutation Spectrum of Neurofibromatosis Type 1 in 27 Turkish Families.
    Sharifi S; Kalaycı T; Palanduz Ş; Öztürk Ş; Cefle K
    Balkan Med J; 2021 Nov; 38(6):365-373. PubMed ID: 34860164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?
    Pasmant E; Parfait B; Luscan A; Goussard P; Briand-Suleau A; Laurendeau I; Fouveaut C; Leroy C; Montadert A; Wolkenstein P; Vidaud M; Vidaud D
    Eur J Hum Genet; 2015 May; 23(5):596-601. PubMed ID: 25074460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
    Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
    J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty-nine novel neurofibromatosis 1 (NF1) gene mutations identified in Slovak patients.
    Nemethova M; Bolcekova A; Ilencikova D; Durovcikova D; Hlinkova K; Hlavata A; Kovacs L; Kadasi L; Zatkova A
    Ann Hum Genet; 2013 Sep; 77(5):364-79. PubMed ID: 23758643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.
    Sabbagh A; Pasmant E; Imbard A; Luscan A; Soares M; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanné-Chantelot C; Vidaud D; Parfait B; Wolkenstein P
    Hum Mutat; 2013 Nov; 34(11):1510-8. PubMed ID: 23913538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1.
    Wang W; Qin W; Ge H; Kong X; Xie C; Tang Y; Li M
    Mol Biol Rep; 2019 Aug; 46(4):4349-4359. PubMed ID: 31201679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.